Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Association of TRAF1/C5 locus polymorphisms with epilepsy and clinical traits in Mexican neurocysticercosis patients.

Villegas M, Sciutto E, Rosetti M, Fleury A, Fragoso G.

Infect Immun. 2019 Sep 30. pii: IAI.00347-19. doi: 10.1128/IAI.00347-19. [Epub ahead of print]

PMID:
31570557
2.

Distribution and molecular characterization of beta-lactamases in Gram-negative bacteria in Colombia, 2001-2016

Rada AM, Hernández-Gómez C, Restrepo E, Villegas MV.

Biomedica. 2019 May 1;39(s1):199-220. doi: 10.7705/biomedica.v39i3.4351. English, Spanish.

3.

Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015

Oñate-Gutiérrez JM, Segura J, Correa A, Cantor E, Villegas MV.

Biomedica. 2019 May 1;39(s1):63-70. doi: 10.7705/biomedica.v39i2.3950. English, Spanish.

4.

Liquid-Infused Surfaces: A Review of Theory, Design, and Applications.

Villegas M, Zhang Y, Abu Jarad N, Soleymani L, Didar TF.

ACS Nano. 2019 Aug 27;13(8):8517-8536. doi: 10.1021/acsnano.9b04129. Epub 2019 Aug 9.

PMID:
31373794
5.

Botulinum toxin and occupational therapy for Writer's cramp.

Park JE, Shamim EA, Panyakaew P, Mathew P, Toro C, Sackett J, Karp B, Lungu C, Alter K, Wu T, Ahmad OF, Villegas M, Auh S, Hallett M.

Toxicon. 2019 Nov;169:12-17. doi: 10.1016/j.toxicon.2019.07.010. Epub 2019 Jul 24.

PMID:
31351085
6.

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia.

Ordóñez K, Feinstein MM, Reyes S, Hernández-Gómez C, Pallares C, Villegas MV.

Braz J Infect Dis. 2019 Jul - Aug;23(4):237-245. doi: 10.1016/j.bjid.2019.06.010. Epub 2019 Jul 22.

7.

Films based on the biopolymer poly(3-hydroxybutyrate) as platforms for the controlled release of dexamethasone.

Villegas M, Cid AG, Briones CA, Romero AI, Pistán FA, Gonzo EE, Gottifredi JC, Bermúdez JM.

Saudi Pharm J. 2019 Jul;27(5):694-701. doi: 10.1016/j.jsps.2019.04.004. Epub 2019 Apr 2.

8.

[Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].

Cuesta DP, Blanco VM, Vallejo ME, Hernández-Gómez C, Maya JJ, Motoa G, Correa A, Matta L, Rosso F, Camargo RD, Muñoz M, Florez E, Nagles J, Ovalle A, Reyes S, Villegas MV.

Rev Chilena Infectol. 2019 Feb;36(1):9-15. doi: 10.4067/S0716-10182019000100009. Spanish.

9.

Promoting physical activity among cancer survivors: Meta-analysis and meta-CART analysis of randomized controlled trials.

Sheeran P, Abraham C, Jones K, Villegas ME, Avishai A, Symes YR, Ellinger H, Miles E, Gates KM, Wright CE, Ribisl KM, Mayer DK.

Health Psychol. 2019 Jun;38(6):467-482. doi: 10.1037/hea0000712. Epub 2019 Apr 11.

PMID:
30973743
10.

Poly(acrylic acid)-Coated Iron Oxide Nanoparticles interact with mononuclear phagocytes and decrease platelet aggregation.

Villegas MG, Ceballos MT, Urquijo J, Torres EY, Ortiz-Reyes BL, Arnache-Olmos OL, López MR.

Cell Immunol. 2019 Apr;338:51-62. doi: 10.1016/j.cellimm.2019.03.005. Epub 2019 Mar 26.

PMID:
30928015
11.

Detection of carbapenemase-producing Pseudomonas aeruginosa: Evaluation of the carbapenem inactivation method (CIM).

Gutiérrez S, Correa A, Hernández-Gómez C, De La Cadena E, Pallares C, Villegas MV.

Enferm Infecc Microbiol Clin. 2019 Mar 18. pii: S0213-005X(19)30127-2. doi: 10.1016/j.eimc.2019.02.004. [Epub ahead of print] English, Spanish.

PMID:
30898368
12.

Multiplex Viral Detection Platform Based on a Aptamers-Integrated Microfluidic Channel.

Saraf N, Villegas M, Willenberg BJ, Seal S.

ACS Omega. 2019 Jan 31;4(1):2234-2240. doi: 10.1021/acsomega.8b03277. Epub 2019 Jan 29.

13.

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Llanos-Cuentas A, Lacerda MVG, Hien TT, Vélez ID, Namaik-Larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, Costa MRF, Chuquiyauri R, Casapía M, Nguyen CH, Aruachan S, Papwijitsil R, Nosten FH, Bancone G, Angus B, Duparc S, Craig G, Rousell VM, Jones SW, Hardaker E, Clover DD, Kendall L, Mohamed K, Koh GCKW, Wilches VM, Breton JJ, Green JA.

N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.

14.

Revisiting the difference between instrumental and terminal values to predict (stimulating) prosocial behaviours: The transcendental-change profile.

Oceja L, Stocks E, Heerdink M, Villar S, Salgado S, Carrera P, Arribas M, Bargsted M, Beramendi M, Caballero A, Espinosa A, Escanés G, Lima L, Muñoz D, Nájera P, Pereira S, Villegas M, Zubieta E.

Br J Soc Psychol. 2019 Jul;58(3):749-768. doi: 10.1111/bjso.12306. Epub 2018 Dec 12.

PMID:
30548477
15.

Gram-negative infections: evolving treatments with expanding options.

Villegas MV, Lyon S.

Future Sci OA. 2018 Sep 27;4(9):FSO339. doi: 10.4155/fsoa-2018-0071. eCollection 2018 Oct.

16.

[Histiocitosis de células de Langerhans con compromiso vertebral].

Giraldo-Grueso M, Villegas MC, Rodríguez DL, Rodríguez E.

Bol Med Hosp Infant Mex. 2018;75(5):309-312. doi: 10.24875/BMHIM.M18000024. Spanish.

PMID:
30250322
17.

13Check_RNA: a tool to evaluate 13C chemical shift assignments of RNA.

Icazatti AA, Martin OA, Villegas M, Szleifer I, Vila JA.

Bioinformatics. 2018 Dec 1;34(23):4124-4126. doi: 10.1093/bioinformatics/bty470.

PMID:
29931233
18.

Collagenase nanocapsules: An approach to fibrosis treatment.

Villegas MR, Baeza A, Usategui A, Ortiz-Romero PL, Pablos JL, Vallet-Regí M.

Acta Biomater. 2018 Jul 1;74:430-438. doi: 10.1016/j.actbio.2018.05.007. Epub 2018 May 4.

PMID:
29734007
19.

Dissecting the conformational determinants of chitosan and chitlac oligomers.

Esteban C, Donati I, Pantano S, Villegas M, Benegas J, Paoletti S.

Biopolymers. 2018 Jun;109(6):e23221. doi: 10.1002/bip.23221. Epub 2018 May 3.

PMID:
29722914
20.

Nanotechnological Strategies for Protein Delivery.

Villegas MR, Baeza A, Vallet-Regí M.

Molecules. 2018 Apr 25;23(5). pii: E1008. doi: 10.3390/molecules23051008. Review.

21.

When does risk perception predict protection motivation for health threats? A person-by-situation analysis.

Ferrer RA, Klein WMP, Avishai A, Jones K, Villegas M, Sheeran P.

PLoS One. 2018 Mar 1;13(3):e0191994. doi: 10.1371/journal.pone.0191994. eCollection 2018.

22.

Fabricating smooth PDMS microfluidic channels from low-resolution 3D printed molds using an omniphobic lubricant-infused coating.

Villegas M, Cetinic Z, Shakeri A, Didar TF.

Anal Chim Acta. 2018 Feb 13;1000:248-255. doi: 10.1016/j.aca.2017.11.063. Epub 2017 Nov 30.

PMID:
29289317
23.

Molecular characterisation of carbapenem-resistant Enterobacter cloacae complex in Colombia: blaKPC and the 'changing landscape'.

De La Cadena E, Correa A, Muñoz JS, Rojas LJ, Hernández-Gómez C, Pallares C, Perez F, Bonomo RA, Villegas MV.

J Glob Antimicrob Resist. 2018 Jun;13:184-189. doi: 10.1016/j.jgar.2017.12.008. Epub 2017 Dec 20.

PMID:
29274468
24.

A persistent lack of international representation on editorial boards in environmental biology.

Espin J, Palmas S, Carrasco-Rueda F, Riemer K, Allen PE, Berkebile N, Hecht KA, Kastner-Wilcox K, Núñez-Regueiro MM, Prince C, Rios C, Ross E, Sangha B, Tyler T, Ungvari-Martin J, Villegas M, Cataldo TT, Bruna EM.

PLoS Biol. 2017 Dec 12;15(12):e2002760. doi: 10.1371/journal.pbio.2002760. eCollection 2017 Dec.

25.

Development of a Mixed Methods Investigation of Process and Outcomes of Community-Based Participatory Research.

Lucero J, Wallerstein N, Duran B, Alegria M, Greene-Moton E, Israel B, Kastelic S, Magarati M, Oetzel J, Pearson C, Schulz A, Villegas M, White Hat ER.

J Mix Methods Res. 2018 Jan;12(1):55-74. doi: 10.1177/1558689816633309. Epub 2016 Feb 26.

26.

Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model.

Ferro A, Carbone E, Zhang J, Marzouk E, Villegas M, Siegel A, Nguyen D, Possidente T, Hartman J, Polley K, Ingram MA, Berry G, Reynolds TH, Possidente B, Frederick K, Ives S, Lagalwar S.

PLoS One. 2017 Dec 6;12(12):e0188425. doi: 10.1371/journal.pone.0188425. eCollection 2017.

27.

An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the "Perfect Storm".

Rojas LJ, Weinstock GM, De La Cadena E, Diaz L, Rios R, Hanson BM, Brown JS, Vats P, Phillips DS, Nguyen H, Hujer KM, Correa A, Adams MD, Perez F, Sodergren E, Narechania A, Planet PJ, Villegas MV, Bonomo RA, Arias CA.

J Infect Dis. 2017 Dec 27;217(1):82-92. doi: 10.1093/infdis/jix524.

28.

Lysine-Grafted MCM-41 Silica as an Antibacterial Biomaterial.

Villegas MF, Garcia-Uriostegui L, Rodríguez O, Izquierdo-Barba I, Salinas AJ, Toriz G, Vallet-Regí M, Delgado E.

Bioengineering (Basel). 2017 Sep 26;4(4). pii: E80. doi: 10.3390/bioengineering4040080.

29.

Electrostatic Spray Deposition-Based Manganese Oxide Films-From Pseudocapacitive Charge Storage Materials to Three-Dimensional Microelectrode Integrands.

Agrawal R, Adelowo E, Baboukani AR, Villegas MF, Henriques A, Wang C.

Nanomaterials (Basel). 2017 Jul 26;7(8). pii: E198. doi: 10.3390/nano7080198.

30.

Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016.

Saavedra SY, Diaz L, Wiesner M, Correa A, Arévalo SA, Reyes J, Hidalgo AM, de la Cadena E, Perenguez M, Montaño LA, Ardila J, Ríos R, Ovalle MV, Díaz P, Porras P, Villegas MV, Arias CA, Beltrán M, Duarte C.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e00841-17. doi: 10.1128/AAC.00841-17. Print 2017 Dec.

31.

Association of Nonsteroidal Antiinflammatory Drugs and Postpartum Hypertension in Women With Preeclampsia With Severe Features.

Viteri OA, England JA, Alrais MA, Lash KA, Villegas MI, Ashimi Balogun OA, Chauhan SP, Sibai BM.

Obstet Gynecol. 2017 Oct;130(4):830-835. doi: 10.1097/AOG.0000000000002247.

PMID:
28885417
32.

High-Level Resistance to Colistin Mediated by Various Mutations in the crrB Gene among Carbapenemase-Producing Klebsiella pneumoniae.

Jayol A, Nordmann P, Brink A, Villegas MV, Dubois V, Poirel L.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01423-17. doi: 10.1128/AAC.01423-17. Print 2017 Nov.

33.

Janus Mesoporous Silica Nanoparticles for Dual Targeting of Tumor Cells and Mitochondria.

López V, Villegas MR, Rodríguez V, Villaverde G, Lozano D, Baeza A, Vallet-Regí M.

ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26697-26706. doi: 10.1021/acsami.7b06906. Epub 2017 Aug 7.

PMID:
28759196
34.

Antibiotic stewardship in low- and middle-income countries: the same but different?

Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, Gould I, Levy Hara G.

Clin Microbiol Infect. 2017 Nov;23(11):812-818. doi: 10.1016/j.cmi.2017.07.010. Epub 2017 Jul 14. Review.

35.

Practical workflow for rapid prototyping of radiation therapy positioning devices.

Gensheimer MF, Bush K, Juang T, Herzberg B, Villegas M, Maxim PG, Diehn M, Loo BW Jr.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):442-445. doi: 10.1016/j.prro.2017.05.004. Epub 2017 May 13. No abstract available.

PMID:
28668669
36.

Learning climate and feedback as predictors of dental students' self-determined motivation: The mediating role of basic psychological needs satisfaction.

Orsini C, Binnie V, Wilson S, Villegas MJ.

Eur J Dent Educ. 2018 May;22(2):e228-e236. doi: 10.1111/eje.12277. Epub 2017 Jun 23.

PMID:
28643884
37.

Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population.

Tamma PD, Villegas MV.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e01094-17. doi: 10.1128/AAC.01094-17. Print 2017 Aug.

38.

Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.

Correa A, Del Campo R, Escandón-Vargas K, Perenguez M, Rodríguez-Baños M, Hernández-Gómez C, Pallares C, Perez F, Arias CA, Cantón R, Villegas MV.

Microb Drug Resist. 2018 Jan/Feb;24(1):48-54. doi: 10.1089/mdr.2016.0190. Epub 2017 Jun 1.

39.

A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST.

Viau RA, Kiedrowski LM, Kreiswirth BN, Adams M, Perez F, Marchaim D, Guerrero DM, Kaye KS, Logan LK, Villegas MV, Bonomo RA.

Pathog Immun. 2017;2(1):23-33. doi: 10.20411/pai.v2i1.99. Epub 2017 Feb 1.

40.

Improved Outcomes When Antibiotic Prescribing Guidelines Are Followed by Healthcare Providers: A Colombian Example to Encourage Adherence in Hospital Settings.

Feinstein MM, Escandón-Vargas K, Reyes S, Hernández-Gómez C, Pallares CJ, Villegas MV.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):756-758. doi: 10.1017/ice.2017.45. Epub 2017 Apr 3. No abstract available. Erratum in: Infect Control Hosp Epidemiol. 2018 Jul;39(7):893.

PMID:
28366177
41.

Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status.

Rodríguez-Angulo H, Marques J, Mendoza I, Villegas M, Mijares A, Gironès N, Fresno M.

BMC Infect Dis. 2017 Mar 21;17(1):221. doi: 10.1186/s12879-017-2324-x.

42.

The epidemiology of carbapenemases in Latin America and the Caribbean.

Escandón-Vargas K, Reyes S, Gutiérrez S, Villegas MV.

Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297. doi: 10.1080/14787210.2017.1268918. Epub 2016 Dec 20. Review.

PMID:
27915487
43.

Seasonal patterns in δ2 H values of multiple tissues from Andean birds provide insights into elevational migration.

Villegas M, Newsome SD, Blake JG.

Ecol Appl. 2016 Dec;26(8):2381-2387. doi: 10.1002/eap.1456.

PMID:
27907263
44.

Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.

Alonso EN, Ferronato MJ, Gandini NA, Fermento ME, Obiol DJ, López Romero A, Arévalo J, Villegas ME, Facchinetti MM, Curino AC.

Nutr Cancer. 2017 Jan;69(1):29-43. doi: 10.1080/01635581.2017.1247891. Epub 2016 Nov 28.

PMID:
27892708
45.

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, Cheng AC, Cairns KA, Escandón-Vargas K, Villegas MV, Brink A, van den Bergh D, Mendelson M.

Lancet Infect Dis. 2017 Feb;17(2):e56-e63. doi: 10.1016/S1473-3099(16)30386-3. Epub 2016 Nov 18. Review.

PMID:
27866945
46.

Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator.

Schüler E, Trovati S, King G, Lartey F, Rafat M, Villegas M, Praxel AJ, Loo BW Jr, Maxim PG.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):195-203. doi: 10.1016/j.ijrobp.2016.09.018. Epub 2016 Sep 20.

PMID:
27816362
47.

Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013.

Motoa G, Muñoz JS, Oñate J, Pallares CJ, Hernández C, Villegas MV.

Rev Iberoam Micol. 2017 Jan - Mar;34(1):17-22. doi: 10.1016/j.riam.2016.02.006. Epub 2016 Oct 31.

PMID:
27810262
48.

[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Blanco VM, Maya JJ, Correa A, Perenguez M, Muñoz JS, Motoa G, Pallares CJ, Rosso F, Matta L, Celis Y, Garzon M, Villegas MV.

Enferm Infecc Microbiol Clin. 2016 Nov;34(9):559-565. doi: 10.1016/j.eimc.2015.11.017. Epub 2016 Jan 13. Spanish.

49.

[Clinical and microbiological characteristics of complicated intra-abdominal infection in Colombia: a multicenter study].

Vallejo M, Cuesta DP, Flórez LE, Correa A, Llanos CE, Isaza B, Vanegas S, Osorio J, Casanova L, Villegas MV.

Rev Chilena Infectol. 2016 Jun;33(3):261-7. doi: 10.4067/S0716-10182016000300002. Spanish.

50.

Temporal discrimination threshold with healthy aging.

Ramos VF, Esquenazi A, Villegas MA, Wu T, Hallett M.

Neurobiol Aging. 2016 Jul;43:174-9. doi: 10.1016/j.neurobiolaging.2016.04.009. Epub 2016 Apr 21.

Supplemental Content

Loading ...
Support Center